E-LIB Suche - Ergebnisse für: Enriquez, Monika Maas

1

Parvovirus B19 in Idiopathic Thrombocytopenic Purpura:

Wehmeier, Artur ; Eis‐Hübinger, Anna Maria ; Enriquez, Monika Maas.
Vox Sanguinis. 79 (2000) 2 - p. 118-118 , 2000

Link: https://doi.org/10.1046/..

2

A post hoc analysis of PROTECT VIII kids assessing long‐ter..:

Ahuja, Sanjay ; Biss, Tina ; Maas Enriquez, Monika...
European Journal of Haematology. 112 (2024) 5 - p. 756-764 , 2024

Link: https://doi.org/10.1111/..

3

Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prop..:

Reding, Mark T. ; Simpson, Mindy ; Ducore, Jonathan...
Acta Haematologica. , 2024

Link: https://doi.org/10.1159/..

4

Safety and efficacy of damoctocog alfa pegol prophylaxis in..:

Holme, Pål André ; Poulsen, Lone Hvitfeldt ; Tueckmantel, Claudia...
Haemophilia. 30 (2024) 2 - p. 388-394 , 2024

Link: https://doi.org/10.1111/..

5

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T. ; Pabinger, Ingrid ; Holme, Pål Andrè...
Therapeutic Advances in Hematology. 14 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

6

PROTECT VIII kids extension study: Long‐term safety and eff..:

Mancuso, Maria Elisa ; Biss, Tina ; Fischer, Kathelijn...
Haemophilia. 27 (2021) 3 - p. 434-444 , 2021

Link: https://doi.org/10.1111/..

7

Confirmed long‐term safety and efficacy of prophylactic tre..:

Reding, Mark T. ; Pabinger, Ingrid ; Holme, Pal Andre...
Haemophilia. 27 (2021) 3 - p. , 2021

Link: https://doi.org/10.1111/..

8

BAY 94‐9027 prophylaxis is efficacious and well tolerated f..:

Lalezari, Shadan ; Reding, Mark T. ; Pabinger, Ingrid...
Haemophilia. 25 (2019) 6 - p. 1011-1019 , 2019

Link: https://doi.org/10.1111/..

9

Matching-adjusted indirect comparisons of efficacy of BAY 8..:

Li, Nanxin ; Pocoski, Jennifer ; Ayyagari, Rajeev...
Journal of Blood Medicine. 7 (2016) - p. 129-137 , 2016

Link: https://doi.org/10.2147/..

10

BAY 81-8973, a full-length recombinant factor VIII: Human h..:

Maas Enriquez, Monika ; Thrift, John ; Garger, Stephen.
Protein Expression and Purification. 127 (2016) - p. 111-115 , 2016

Link: https://doi.org/10.1016/..

11

Sucrose-Formulated Recombinant Factor VIII Dosing Flexibili..:

Humphries, Thomas J. ; Rauchensteiner, Stephan ; Tückmantel, Claudia...
Advances in Hematology. 2015 (2015) - p. 1-6 , 2015

Link: https://doi.org/10.1155/..

12

Confirmed long-term safety and efficacy of prophylactic tre..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pal Andre...
https://research.rug.nl/en/publications/e79da4e3-bf7a-4fae-ac07-79542e597252. , 2021

Link: https://hdl.handle.net/1..

13

BAY 94-9027 prophylaxis is efficacious and well tolerated f..:

Lalezari, Shadan ; Reding, Mark T ; Pabinger, Ingrid...
http://urn.nb.no/URN:NBN:no-79011. , 2020

Link: http://hdl.handle.net/10..

14

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Mark T. Reding ; Ingrid Pabinger ; Pål Andrè Holme...
https://doi.org/10.1177/20406207231166779. , 2023

Link: https://doi.org/10.1177/..

15

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andre...
Reding, Mark T. Pabinger, Ingrid Holme, Pål Andre Maas Enriquez, Monika Mancuso, Maria Elisa Lalezari, Shadan Miesbach, Wolfgang Di Minno, Giovanni Klamroth, Robert Hermans, Cedric . Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study. Therapeutic Advances in Hematology (TAH). 2023, 14. , 2023

Link: http://hdl.handle.net/10..